Vaccination over the age of 75 on the 1st of next month…Pfizer vaccine will be on the 24th for 250,000 people

250,000 Pfizer vaccine doses (500,000 doses) to be vaccinated by seniors aged 75 or older will arrive in Korea on the morning of the 24th.

On the 20th, the second vaccination of Pfizer's vaccine was conducted for workers in medical institutions treating COVID-19 patients, medical staff are preparing for vaccination at the vaccination center of the National Medical Center in Jongno-gu.  yunhap news

On the 20th, the second vaccination of Pfizer’s vaccine was conducted for workers in medical institutions treating COVID-19 patients, medical staff are preparing for vaccination at the vaccination center of the National Medical Center in Jongno-gu. yunhap news

According to the Novel Coronavirus Infectious Disease (Corona 19) Vaccination Promotion Team on the 23rd, 250,000 out of the 13 million vaccines secured through a direct contract with Pfizer of the U.S. arrived at Incheon Airport by UPS cargo airline 5×0196 flight at 7:45 am on the 24th. do.

The delivered vaccine will be delivered to 46 regional vaccination centers nationwide, and will be vaccinated to seniors aged 75 or older starting from the 1st of next month. A total of 3.64 million people are eligible for vaccination over the age of 75 residing in the community.

A total of 3.5 million Pfizer vaccines will be secured by the government by the second quarter. At the end of this month, an additional 250,000 people will enter, and in the second quarter, an additional 3 million people will come in.

The government has signed a vaccine purchase contract for a total of 79 million people so far. It secured 10 million people through Kovacs, and signed 69 million people with individual pharmaceutical companies. The volume of pharmaceutical companies is for AstraZeneca 10 million, Pfizer 13 million, Janssen 6 million, Modena 20 million, and NovaVax 20 million.

Earlier in February, 58,000 Pfizer vaccines were received through Kovacs, and 787,000 were received from AstraZeneca. Novabacks, Janssen, and Modena are discussing the schedule for introduction.

Reporter Shin Hyeyeon [email protected]


Source